Intervention not reported
Death from any cause prior to hospital discharge · Neonates with PPHN
The intervention showed no clear difference in death from any cause prior to hospital discharge (low certainty).
1 finding from 1 review
RR 0.2 [0.02, 1.77]
37 participants
Low
Intervention not reported
Percentage of infants that showed improvement in OI by at least 20% by the end of therapy · Neonates with PPHN
1 finding from 1 review
no estimate extracted
39 participants
Low
Intervention not reported
Adverse neurological outcomes at six months of age · Neonates with PPHN
1 finding from 1 review
no estimate extracted
37 participants
Low
Intervention not reported
Cerebral Palsy · Neonates with PPHN
1 finding from 1 review
no estimate extracted
37 participants
Low
Intervention not reported
Deafness · Neonates with PPHN
1 finding from 1 review
no estimate extracted
37 participants
Low
Intervention not reported
Need for ECMO prior to discharge · Neonates with PPHN
1 finding from 1 review
no estimate extracted
21 participants
Low
Intervention not reported
Total duration of mechanical ventilation (days) · Neonates with PPHN
The intervention showed no clear difference in total duration of mechanical ventilation (days) (low certainty).
1 finding from 1 review
no estimate extracted
37 participants
Low
Intervention not reported
Duration of iNO therapy (days) · Neonates with PPHN
1 finding from 1 review
no estimate extracted
21 participants
Low
Intervention not reported
Total duration of mechanical ventilation (days) · Neonates with PPHN
1 finding from 1 review
no estimate extracted
21 participants
Low
Intervention not reported
Incident dementia ‐ not measured · adults with cognitive impairment/dementia and cognitively intact populations
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Cognition (at 90 days): t‐MMSE score1 · adults with cognitive impairment/dementia and cognitively intact populations
1 finding from 1 review
Intervention not reported
Composite cognitive function6 (change over 16 weeks) · adults with cognitive impairment/dementia and cognitively intact populations
1 finding from 1 review
Intervention not reported
Mortality (at 3 to 4 months' · adults with cognitive impairment/dementia and cognitively intact populations
The intervention showed no clear difference in mortality (at 3 to 4 months' (moderate certainty).
1 finding from 1 review
Intervention not reported
Cardiovascular events (at 3 to 4 months' · adults with cognitive impairment/dementia and cognitively intact populations
The intervention showed no clear difference in cardiovascular events (at 3 to 4 months' (low certainty).
1 finding from 1 review
Intervention not reported
Falls ‐ not measured · adults with cognitive impairment/dementia and cognitively intact populations
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Hospitalisations (at 4 months' · adults with cognitive impairment/dementia and cognitively intact populations
The intervention showed no clear difference in hospitalisations (at 4 months' (low certainty).
1 finding from 1 review
Gestational age (preterm birth < 37 weeks) · healthy pregnant women receiving calcium supplementation vs placebo or no treatment
Calcium supplementation showed no clear difference in preterm birth (a) Birth prior to 37 weeks compared with placebo or no treatment (maternal outcomes) (moderate certainty).
1 finding from 1 review
Preterm birth less than 34 weeks' gestation · healthy pregnant women receiving calcium supplementation vs placebo or no treatment
Calcium supplementation showed no clear difference in preterm birth (b) Birth prior to 34 weeks compared with placebo or no treatment (maternal outcomes) (moderate certainty).
1 finding from 1 review
Low birthweight · healthy pregnant women receiving calcium supplementation vs placebo or no treatment
Calcium supplementation showed no clear difference in low birthweight (< 2500 g) compared with placebo or no treatment (maternal outcomes) (moderate certainty).
1 finding from 1 review
Intervention not reported
Functional exercise capacity Multiple different outcome measures used SF‐36 PF and AT (at 9 and 26 weeks) (Batterham 2014) SF‐36 PF and 6MWT (at 8 and 26 weeks) (Elliott 2011) ABC, Katz, TUAG (at 3 months) (Jackson 2012) SF‐36 PCS ( · adult survivors of critical illness
1 finding from 1 review